{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:09Z","timestamp":1761986469524},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,10,21]],"date-time":"2012-10-21T00:00:00Z","timestamp":1350777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00292-012-1654-0","type":"journal-article","created":{"date-parts":[[2012,10,19]],"date-time":"2012-10-19T11:14:12Z","timestamp":1350645252000},"page":"539-552","source":"Crossref","is-referenced-by-count":2,"title":["Mastozytosen und myeloische Neoplasien mit Eosinophilie"],"prefix":"10.1007","volume":"33","author":[{"given":"K.","family":"Sotlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-P.","family":"Horny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,21]]},"reference":[{"key":"1654_CR1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","volume":"37","author":"Valent","year":"2007","unstructured":"Valent P, Akin C, Escribano L et al (2007) Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 37:435\u2013453","journal-title":"Eur J Clin Invest"},{"key":"1654_CR2","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1172\/JCI118337","volume":"96","author":"Schwartz","year":"1995","unstructured":"Schwartz LB, Sakai K, Bradford TR et al (1995) The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 96:2702\u20132710","journal-title":"J Clin Invest"},{"key":"1654_CR3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9440(10)63870-9","volume":"162","author":"Sotlar","year":"2003","unstructured":"Sotlar K, Escribano L, Landt O et al (2003) One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes. Am J Pathol 162:737\u2013746","journal-title":"Am J Pathol"},{"key":"1654_CR4","unstructured":"Horny H-P, Metcalfe DD, Bennett JM et al (2008) Mastocytosis (Mast cell disease). In: Campo E, Swerdlow SH, Harris NL, Jaffe ES (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Geneva, S\u00a054\u201363"},{"key":"1654_CR5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","volume":"57","author":"Horny","year":"2004","unstructured":"Horny HP, Sotlar K, Sperr WR et al (2004) Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 57:604\u2013608","journal-title":"J Clin Pathol"},{"key":"1654_CR6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","volume":"220","author":"Sotlar","year":"2010","unstructured":"Sotlar K, Colak S, Bache A et al (2010) Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J Pathol 220:586\u2013595","journal-title":"J Pathol"},{"key":"1654_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0145-2126(01)00021-2","volume":"25","author":"Horny","year":"2001","unstructured":"Horny HP, Valent P (2001) Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 25:543\u2013551","journal-title":"Leuk Res"},{"key":"1654_CR8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jcp.56.8.575","volume":"56","author":"Horny","year":"2003","unstructured":"Horny HP, Lange K, Sotlar K et al (2003) Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens. J Clin Pathol 56:575\u2013578","journal-title":"J Clin Pathol"},{"key":"1654_CR9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1309\/CX45R79PCU9HCV6V","volume":"124","author":"Krokowski","year":"2005","unstructured":"Krokowski M, Sotlar K, Krauth MT et al (2005) Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. Am J Clin Pathol 124:560\u2013568","journal-title":"Am J Clin Pathol"},{"key":"1654_CR10","first-page":"1493","volume":"149","author":"Orfao","year":"1996","unstructured":"Orfao A, Escribano L, Villarrubia J et al (1996) Flow cytometric analysis of mast cells from normal and pathological human bone marrow samples: identification and enumeration. Am J Pathol 149:1493\u20131499","journal-title":"Am J Pathol"},{"key":"1654_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/hupa.2001.24319","volume":"32","author":"Jordan","year":"2001","unstructured":"Jordan JH, Walchshofer S, Jurecka W et al (2001) Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117\/Kit, and bcl-x(L). Hum Pathol 32:545\u2013552","journal-title":"Hum Pathol"},{"key":"1654_CR12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jcp.2005.028738","volume":"59","author":"Horny","year":"2006","unstructured":"Horny HP, Sotlar K, Stellmacher F et al (2006) The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 59:298\u2013302","journal-title":"J Clin Pathol"},{"key":"1654_CR13","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","volume":"103","author":"Akin","year":"2004","unstructured":"Akin C, Fumo G, Yavuz AS et al (2004) A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood 103:3222\u20133225","journal-title":"Blood"},{"key":"1654_CR14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","volume":"24","author":"Sotlar","year":"2011","unstructured":"Sotlar K, Cerny-Reiterer S, Petat-Dutter K et al (2011) Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol 24:585\u2013595","journal-title":"Mod Pathol"},{"key":"1654_CR15","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"Longley","year":"1999","unstructured":"Longley BJ Jr, Metcalfe DD, Tharp M et al (1999) Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A 96:1609\u20131614","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1654_CR16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jcp.2003.012864","volume":"57","author":"Bernd","year":"2004","unstructured":"Bernd HW, Sotlar K, Lorenzen J et al (2004) Acute myeloid leukaemia with t(8;21) associated with \u201eoccult\u201c mastocytosis. Report of an unusual case and review of the literature. J Clin Pathol 57:324\u2013328","journal-title":"J Clin Pathol"},{"key":"1654_CR17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2353\/jmoldx.2008.070061","volume":"10","author":"Sotlar","year":"2008","unstructured":"Sotlar K, Bache A, Stellmacher F et al (2008) Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 10:58\u201366","journal-title":"J Mol Diagn"},{"key":"1654_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000305552","volume":"77","author":"Horny","year":"2010","unstructured":"Horny HP, Sotlar K, Valent P (2010) Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review. Pathobiol 77:169\u2013180","journal-title":"Pathobiol"},{"key":"1654_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12308-011-0094-8","volume":"4","author":"Horny","year":"2011","unstructured":"Horny H-P, Sotlar K, Valent P (2011) Eosinophil, basophil, and mast cell infiltrates in the bone marrow: crossing the boundaries of diagnosis. J Hematopathol 4:101\u2013111","journal-title":"J Hematopathol"},{"key":"1654_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood.V40.4.464.464","volume":"40","author":"Rywlin","year":"1972","unstructured":"Rywlin AM, Hoffman EP, Ortega RS (1972) Eosinophilic fibrohistiocytic lesion of bone marrow: a distinctive new morphologic finding, probably related to drug hypersensitivity. Blood 40:464\u2013472","journal-title":"Blood"},{"key":"1654_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00507129","volume":"377","author":"Velde","year":"1978","unstructured":"Velde J te, Vismans FJ, Leenheers-Binnendijk L et al (1978) The eosinophilic fibrohistiocytic lesion of the bone marrow. A mastocellular lesion in bone disease. Virchows Arch A Pathol Anat Histol 377:277\u2013285","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"1654_CR22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0145-2126(01)00040-6","volume":"25","author":"Valent","year":"2001","unstructured":"Valent P, Sperr WR, Samorapoompichit P et al (2001) Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis. Leuk Res 25:595\u2013602","journal-title":"Leuk Res"},{"key":"1654_CR23","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","volume":"98","author":"Sperr","year":"2001","unstructured":"Sperr WR, Jordan JH, Baghestanian M et al (2001) Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 98:2200\u20132209","journal-title":"Blood"},{"key":"1654_CR24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/10428190290012065","volume":"43","author":"Jordan","year":"2002","unstructured":"Jordan JH, Schernthaner GH, Fritsche-Polanz R et al (2002) Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria. Leuk Lymphoma 43:575\u2013582","journal-title":"Leuk Lymphoma"},{"key":"1654_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000336374","volume":"159","author":"Horny","year":"2012","unstructured":"Horny H-P, Sotlar K, Valent P (2012) Evaluation of mast cell activation syndromes: impact of pathology and immunohistology. Int Arch Allergy Immunol 159:1\u20135","journal-title":"Int Arch Allergy Immunol"},{"key":"1654_CR26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7326\/0003-4819-68-6-1220","volume":"68","author":"Hardy","year":"1968","unstructured":"Hardy WR, Anderson RE (1968) The hypereosinophilic syndromes. Ann Intern Med 68:1220\u20131229","journal-title":"Ann Intern Med"},{"key":"1654_CR27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","volume":"130","author":"Valent","year":"2012","unstructured":"Valent P, Klion AD, Horny HP et al (2012) Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 130(3):607\u2013612","journal-title":"J Allergy Clin Immunol"},{"key":"1654_CR28","unstructured":"Bain BJ, Gilliland DG, Vardiman JW, Horny H-P (2008) Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Campo E, Swerdlow SH, Harris NL, Jaffe ES (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Geneva, pp\u00a068\u201373"},{"key":"1654_CR29","unstructured":"Bain BJ, Gilliland DG, Vardiman JW, Horny H-P (2008) Chronic eosinophilic leukemia, not otherwise specified. In: Campo E, Swerdlow SH, Harris NL, Jaffe ES (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Geneva, pp\u00a051\u201353"},{"key":"1654_CR30","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1158\/0008-5472.CAN-04-4263","volume":"65","author":"Reiter","year":"2005","unstructured":"Reiter A, Walz C, Watmore A et al (2005) The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2. Cancer Res 65:2662\u20132667","journal-title":"Cancer Res"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1654-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-012-1654-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-012-1654-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T23:39:18Z","timestamp":1594769958000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-012-1654-0"}},"subtitle":["Diagnostik und Klassifikation"],"short-title":[],"issued":{"date-parts":[[2012,10,21]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1007\/s00292-012-1654-0","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,21]]}}}